Results 61 to 70 of about 105,391 (147)

Physiologically‐Based Pharmacokinetic Modeling of the PARP Inhibitor Niraparib

open access: yesCPT: Pharmacometrics & Systems Pharmacology
A physiologically‐based pharmacokinetic (PBPK) model of niraparib and its primary metabolite using a relevant virtual cancer population is reported here. A series of in vitro experiments using liver S9, microsomes, and hepatocytes with various inhibitors
Gareth J. Lewis   +3 more
doaj   +1 more source

Computational modelling and simulation for immunotoxicity prediction induced by skin sensitisers. [PDF]

open access: yesComput Struct Biotechnol J, 2022
Russo G   +6 more
europepmc   +1 more source

Data-driven queueing modelling: a simulation case study of emergency department crowding. [PDF]

open access: yesBMJ Health Care Inform
Wartelle A   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy